Malaysian Genomics Resource Centre to Offer Pioneering Holistic Renal Care via New Venture

PETALING JAYA, Malaysia, Jun 23, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is acquiring a 51% stake in Aquahealth Sdn Bhd, a kidney dialysis operator, from Rinani Renal Berhad. En. Sasha Nordin, Chief Executive Officer of […]

Malaysian Genomics Resource Centre Berhad Gets Affected Issuer Status Uplifted

PETALING JAYA, Malaysia, Jun 13, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that it is uplifted from being classified as an affected listed corporation effective 13 June 2022. Azri Azerai, Executive Director of Malaysian Genomics Sasha Nordin, […]

Malaysian Genomics Resource Centre Berhad Posts 212% Increase in Revenue for 3Q FY2022

PETALING JAYA, Malaysia, May 23, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group registered a 211.66% increase in revenue to RM5.08 million for the third quarter ended 31 March 2022 (3Q 2022) compared with revenue of RM1.63 million for the […]

Malaysian Genomics Resource Centre Berhad Supports Yayasan Seri Negara’s Ramadhan Initiative

PETALING JAYA, Malaysia, Apr 28, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to support Yayasan Seri Negara’s (YSN) Ihya Ramadhan 2022 programme through a monetary donation to help those in need. Dato’ Seri Mazlan Lazim, Patron of Yayasan Seri […]

Malaysian Genomics Resource Centre Berhad Awarded Covid-19 Surveillance Contract

PETALING JAYA, Malaysia, Apr 4, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (“Malaysian Genomics” or “the Group”), a leading genomics and biopharmaceutical specialist, was recently awarded a COVID-19 surveillance contract by the Institute for Medical Research (“IMR”), the biomedical research arm of the Ministry of Health (“MOH”). Malaysian Genomics is […]

ACT Genomics and Sanomics Merge to Unleash Hong Kong’s Global Potential in Healthcare Technology

HONG KONG, Nov 22, 2021 – (ACN Newswire via SEAPRWire.com) – ACT Genomics Holdings Co. Ltd. (“ACT Genomics” or “the Group”) a leading cancer solution provider in Asia, announced today that it has merged with Sanomics Holdings Limited (“Sanomics”), a champion in lung cancer diagnostics in Hong Kong and Thailand. Both ACT Genomics and Sanomics […]

ACT Genomics Completes Acquisition of MC Diagnostics

HONG KONG, Jul 6, 2021 – (ACN Newswire via SEAPRWire.com) – ACT Genomics Co. Ltd. (“ACT Genomics” or “the Group”) has completed the acquisition of MC Diagnostics Ltd. (“MCD”), a specialist molecular diagnostic company based in the United Kingdom, which marks the Group’s entry into the European precision medicine market. MCD machine in operation Founded […]